1Inspiration of the extension of duration of patent right in Japan to new drug research and development in ChinaGU Dong-lei, PAN Xiao-mei, YANG Jing289-2942Research on European supplementary protection certificate and development tendencyLIU Qing, HUANG Chao-feng295-2993Discussion on pharmaceutical characteristics and common problems in manufacturing site inspection of lipid-altering drugsLIU Meng-si, SONG Dan, LIU Jin-xin300-3054Overview of nonclinical safety evaluation methods and techniques for drug-induced neurotoxicityTIAN Kang, QU Zhe, L(U) Jian-jun, WANG Xue, GENG Xing-chao, LI Bo, HUANG Zhi-ying306-3115A survey on cognition about quality control of clinical trial institutionsXIAO Shuang, WANG Yan, ZHU Xue-qi, CHENG Jin-lian312-3196A discussion on the quality evaluation practice of human embryonic stem cells-derived hepatocyte-like cellsNA Tao, SUN Yi, WU Ting-ting, OUYANG Qi, LU Guang-xiu, LIN Ge, YUAN Bao-zhu320-3327Research advance in quality control of protein-based nano-preparationsZHANG Jin-xia, LI Nan, LI Xiao-qin, WANG Qian-wen, DENG Sheng-qi333-3388Research progress in detection of active ingredients in traditional Chinese medicine based on immunoassayZHU Rui-xuan, ZHANG Miao, WANG Peng-qian, HUO Hai-ru, LI Wen-lan, SUI Feng339-3469Research progress on extraction methods and pharmacological effects of eucommia ulmoides polysaccharideZHANG Xiao-fang, HU Wen-zhong, JIANG Ai-li, FENG Ke, HOU Meng-yang347-35110Effect of obeticholic acid on glycolipid homeostasis in type 2 diabetic KKAy miceCAO Hui, HUAN Yi, LI Cai-na, LIU Shuai-nan, LIU Quan, SUN Su-juan, LEI Lei, SHEN Zhu-fang352-35611Determination of moxifloxacin hydrochloride and it's impurity 7-amino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid by 1H qNMRFENG Yu-fei, WU Xian-fu, XIAO Xin-yue357-36112Research on TLC identification and content determination of Shencao Ningxin GranulesDUAN Xiu-jun, LIU Pei, YE Hua, WANG Yi-nan, DONG Zheng-yan, YAO Long-dan, YANG Chao, DUAN Qing-qing362-36813Literature analysis of adverse drug reactions induced by tocilizumabSHU Bing, JIANG Wei, SHEN Ai-zong369-37614Pharmacoeconomic evaluation of CAR-T therapy for two hematological malignancies: a systematic reviewDAI Zhan-jing, CHANG Feng, HUANG Yan-qin, LIU Yang, LU Yun377-384